Health
Baricitinib treatment linked to reduced mortality in COVID-19 patients – EurekAlert
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
IMAGE: Volker M. Lauschke, associate professor
Department of Physiology and Pharmacology, Karolinska Institutet.
view more
Credit: Jannis Politidis
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing…
-
General23 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News16 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News17 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News23 hours agoScenic Rim council cracks down on farmers hosting campers without a permit